@megtirrell @CNBC MegT=best pharma/bio reporter on planet. Can we add some coverage on promising therapeutics about to go into trial like Ph 2 oral host directed $BSGM drug in combo with $GILD REM with @mayoclinic COVID chairman as PI with ex $CELG CMO &amp; $MRK vaccine head  https://t.co/m5i1M4PBd7